期刊文献+

伊班磷酸钠与帕米磷酸钠对肺癌骨转移的疗效 被引量:1

Study the Effect of Pamidronate Disodium and Ibandronate Monosodium for Lung Cancer with Bone Metastasis
下载PDF
导出
摘要 目的比较伊班磷酸钠与帕米磷酸钠对肺癌骨转移的疗效。方法将73例肺癌骨转移患者随机分成2组,分别给予伊班磷酸钠和帕米磷酸钠进行治疗,疗程均为4个月,观察其疗效。结果伊班磷酸钠组和帕米磷酸钠组的起效时间分别为(26.4±3.6)h和(68.2±7.7)h,疗程结束后镇痛有效率分别为88.9%和66.7%,骨相关事件累计发生率分别为11.1%和25.0%,血钙水平分别为(1.66±0.14)mmol/L和(2.21±0.15)mmol/L,两组间差别均有统计学意义(P<0.05)。结论伊班磷酸钠比帕米磷酸钠对肺癌骨转移起效快,镇痛作用更有效,预防骨相关事件和降低血钙水平作用更强。 Objective To compare the effect of two kind of sodium sults on the treatment of lung cancer with bone metastasis.Methods 73 patients of lung cancer with bone metastasis were divided into two groups.They were respectively given pamidronate disodium or ibandronate monosodium for 4 months.Results Onset time of the medications in the two groups were 26.4±3.6h vs 68.2±7.7h,Skeletal Related Event(SRE)cumulative incident rates were13.5% vs 25%,Serum concentration of calcium were 2.21±0.15 mmol/l vs 1.66±0.14 mmol/l.Conclusions Compared with the pamidronate disodium,the ibandronate monosodium showed a faster onset time and stronger action to prevent SRE and reduce calcium levels in paitents of lung cancer with bone metastasis.
作者 尹宇杰
出处 《中国慢性病预防与控制》 CAS 2008年第3期287-288,共2页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 肺肿瘤 肿瘤转移 帕米磷酸钠 伊班磷酸钠 Lung cancer Neoplasm metastasis Pamidronate disodium Ibandronate monosodium
  • 相关文献

参考文献4

二级参考文献4

共引文献61

同被引文献16

  • 1张永学,黄钢.核医学.第2版.北京:人民卫生出版社,2010:209-233.
  • 2曹来宾,王安明,徐爱德,何树岗,田维泽,江志勇,许祖闪,吴树森,王天保,陈宝仓,高士伟,王学庆,田军,孟凡录,李先启,庄悦新,秦东京,殷焕起,唐志学,臧宝江,唐桂长,崔华兴,徐万峰,李会祥,王国华,周海舟,周韶龙,衣建安.1047例骨转移瘤的影像学诊断[J].中华放射学杂志,1997,31(8):547-551. 被引量:102
  • 3Siegel R,Ma JM,Zou ZH,et al.Cancer statistics,2014.CA Cancer J Clin,2014,64(1):9-29.
  • 4Hao J,Chen WQ.Beijing:2012 Chinese cancer registry annual report.Beijing:military medical science press,2012.
  • 5Lemieux J,Guimond J,Laberge F,et al.The bone scan flare phenomenon in non-small-cell lung cancer.Clin Nucl Med,2002,27(7):486-489.
  • 6Chao HS,Chang CP,Chiu CH,et al.Bone scan flare phenomenon in non-small-cell lung cancer patients treated with gefitinib.Clin Nucl Med,2009,34(6):346-349.
  • 7Hamaoka T,Madewell JE,Podoloff DA,et al.Bone imaging in metastatic breast cancer.J Clin Oncol,2004,22(14):2942-2953.
  • 8Hayashi N,Costelloe CM,Hamaoka T,et al.A prospective study of bone tumor response assessment in metastatic breast cancer.Clin Breast Cancer,2013,13(1):24-30.
  • 9Eisenhauer EA,Therasse P,Bogaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1).Eur J Cancer,2009,45(2):228-247.
  • 10Wilson MA,Calhoun FW.The distribution of skeletal m e t a s t a s e s i n b r e a s t a n d p u l m o n a r y c a n c e r:c o n c i s e communication.J Nucl Med,1981,22(7):594-597.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部